Squarepoint’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$338K Buy
625,034
+614,233
+5,687% +$332K ﹤0.01% 2105
2025
Q1
$7.08K Sell
10,801
-699,562
-98% -$459K ﹤0.01% 2705
2024
Q4
$725K Buy
+710,363
New +$725K ﹤0.01% 1728
2024
Q1
Sell
-41,146
Closed -$22.4K 2873
2023
Q4
$22.4K Buy
+41,146
New +$22.4K ﹤0.01% 2422
2022
Q4
Sell
-42,077
Closed -$206K 2580
2022
Q3
$206K Buy
42,077
+26,686
+173% +$131K ﹤0.01% 1787
2022
Q2
$64K Sell
15,391
-8,881
-37% -$36.9K ﹤0.01% 1936
2022
Q1
$141K Buy
+24,272
New +$141K ﹤0.01% 1982
2021
Q3
Sell
-12,573
Closed -$150K 2695
2021
Q2
$150K Sell
12,573
-42,885
-77% -$512K ﹤0.01% 2329
2021
Q1
$695K Sell
55,458
-20,020
-27% -$251K ﹤0.01% 1317
2020
Q4
$1.18M Buy
75,478
+13,098
+21% +$204K 0.01% 976
2020
Q3
$589K Buy
+62,380
New +$589K 0.01% 1229
2020
Q2
Sell
-53,294
Closed -$339K 2418
2020
Q1
$339K Sell
53,294
-52,575
-50% -$334K 0.01% 1238
2019
Q4
$886K Sell
105,869
-68,871
-39% -$576K 0.01% 1386
2019
Q3
$1.58M Buy
174,740
+113,232
+184% +$1.02M 0.01% 934
2019
Q2
$662K Buy
61,508
+24,363
+66% +$262K 0.01% 1480
2019
Q1
$354K Buy
37,145
+17,469
+89% +$166K ﹤0.01% 1632
2018
Q4
$226K Sell
19,676
-16,274
-45% -$187K ﹤0.01% 1627
2018
Q3
$609K Sell
35,950
-27,400
-43% -$464K 0.01% 1219
2018
Q2
$900K Sell
63,350
-57,211
-47% -$813K 0.01% 933
2018
Q1
$2.29M Buy
120,561
+77,725
+181% +$1.48M 0.04% 520
2017
Q4
$703K Buy
+42,836
New +$703K 0.01% 987
2017
Q1
Sell
-39,001
Closed -$119K 1868
2016
Q4
$119K Buy
+39,001
New +$119K ﹤0.01% 1592
2016
Q3
Sell
-15,300
Closed -$89K 1235
2016
Q2
$89K Buy
+15,300
New +$89K 0.01% 988
2016
Q1
Sell
-29,500
Closed -$269K 1423
2015
Q4
$269K Buy
+29,500
New +$269K 0.03% 852